Effects of Ridogrel, a Thromboxane Synthase Inhibitor and Receptor Antagonist, on Blood Pressure in the Spontaneously Hypertensive Rat

この論文にアクセスする

この論文をさがす

著者

    • Quest Dale W. QUEST Dale W.
    • Cardiovascular Risk Factor Reduction Unit (C.R.F.R. U.), Department of Medicine, Division of Clinical Pharmacology,Royal University Hospital
    • Wilson Thomas W. WILSON Thomas W.
    • Cardiovascular Risk Factor Reduction Unit (C.R.F.R. U.), Department of Medicine, Division of Clinical Pharmacology,Royal University Hospital

抄録

Ridogrel is a dual acting thromboxane synthase inhibitor/TP receptor antagonist. We examined the effects of single and multiple doses on systolic blood pressure in stroke-prone spontaneously hypertensive rats. Single doses of ridogrel (5 to 125 mg/kg) did not affect systolic blood pressure or furosemide-stimulated excretion rates of thromboxane B<SUB>2</SUB> or 6-keto-prostaglandin F<SUB>1α</SUB>, although ex vivo serum thromboxane B<SUB>2</SUB> was dose-dependently reduced up to 95%. In contrast, repeated dosing (7 days) with ridogrel (3 to 25 mg/kg/day), had an antihypertensive effect in 12-week-old stroke-prone spontaneously hypertensive rats. At 25 mg/kg/day, ridogrel reduced systolic blood pressure from 200±6.1 to 173±6.7 mmHg (n=12, P<0.01). Ridogrel dose-dependently reduced serum thromboxane B<SUB>2</SUB> and increased plasma renin activity. Unlike single doses, repeated dosing reduced urinary thromboxane B<SUB>2</SUB> excretion (from 103±7 ng/day to 49±10 ng/day, P<0.01) while preserving 6-keto-prostaglandin F<SUB>1α</SUB> excretion. Ketoprofen, a cyclo-oxygenase inhibitor, (10 mg/kg/day for 7 days), depressed urine 6-keto-prostaglandin F<SUB>1α</SUB> in addition to attenuating serum and urine thromboxane B<SUB>2</SUB>. Ketoprofen prevented the antihypertensive effects of ridogrel. Ridogrel did not lower systolic blood pressure in Sprague-Dawley rats. We conclude that the antihypertensive effect of ridogrel involves preserving renal prostaglandin synthesis during thromboxane attenuation.

収録刊行物

  • The Japanese journal of pharmacology

    The Japanese journal of pharmacology 78(4), 479-486, 1998-12-01

    The Japanese Pharmacological Society

参考文献:  52件中 1-52件 を表示

各種コード

  • NII論文ID(NAID)
    10008681847
  • NII書誌ID(NCID)
    AA00691188
  • 本文言語コード
    ENG
  • 資料種別
    ART
  • ISSN
    00215198
  • NDL 記事登録ID
    4629553
  • NDL 雑誌分類
    ZS51(科学技術--薬学)
  • NDL 請求記号
    Z53-D199
  • データ提供元
    CJP書誌  NDL  J-STAGE 
ページトップへ